In this interview, John G. Webb, MD, FACC, discusses his experience with the new devices and provides additional details on the percutaneous procedure itself and patient follow-up.
15d
Hosted on MSNGlucotrack hits trial success for direct blood measuring CGMThe company’s system is placed in the subclavian vein, a blood vessel that runs under the collar bone bringing deoxygenated ...
The following is a summary of “Safety and Efficacy of Rigid Bronchoscopy-guided Percutaneous Dilational Tracheostomy,” ...
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on ...
Japan: A recent study found that severe dysphagia in patients undergoing percutaneous endoscopic gastrostomy (PEG) was linked ...
Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results